The Relevance of Sex and Age as Non-Modifiable Risk Factors in Relation to Clinical-Pathological Parameters in Colorectal Cancer

被引:0
作者
Barna, Robert [1 ]
Dema, Alis [1 ,2 ]
Jurescu, Aura [1 ]
Vaduva, Adrian Ovidiu [1 ,2 ]
Lazureanu, Dorela-Codruta [1 ,2 ]
Vita, Octavia [1 ]
Nataras, Bianca [1 ]
Hurmuz, Ioana [1 ]
Vidac, Adelina [1 ]
Taban, Sorina [1 ,2 ]
Dema, Sorin [3 ,4 ]
机构
[1] Victor Babes Univ Med & Pharm, ANAPATMOL Res Ctr, Dept Microscop Morphol Morphopatol, Timisoara 300041, Romania
[2] Pius Brinzeu Cty Clin Emergency Hosp, Dept Pathol, Timisoara 300723, Romania
[3] Emergency City Clin Hosp Timisoara, Dept Radiotherapy, Timisoara 300079, Romania
[4] Victor Babes Univ Med & Pharm, Dept Oncol, Timisoara 300041, Romania
来源
LIFE-BASEL | 2025年 / 15卷 / 02期
关键词
colorectal cancer; age; sex; young patients; clinical-pathological parameters; TRENDS; COLON; ASSOCIATION; STATISTICS; MORTALITY;
D O I
10.3390/life15020156
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and objectives: We aimed to assess the significance of sex and age compared to other clinical-pathological parameters in colorectal cancer (CRC). Materials and methods: Our study included a retrospective approach to CRC patients who underwent surgery at the 'Pius Brinzeu' County Clinical Emergency Hospital in Timisoara (PBECCHT), Romania. The analyzed parameters were: patient age and sex, tumor location, histological type, differentiation grade (G), extent of tumor (pT), lymph-node status (pN), distant metastasis status (pM), and lymphovascular invasion (LVI). The population was divided into three groups based on age, with those under 49 years old, 50 to 69 years old, and elderly (>70). Results: The study's inclusion criteria were met by 1885 patients, with a male-to-female ratio of 1.39:1. There were significant differences between the sexes in the anatomical location of tumors (p < 0.0001). Younger patients were more likely to have deeply invasive tumors (p = 0.0096), LVI (p = 0.0332), lymph-node metastases (p = 0.0158), and metastatic disease (p = 0.0017). Conclusions: Over the ten-year period reviewed, the frequency of CRC cases has progressively increased, with males being diagnosed more often. In terms of patient age, the young population exhibits clinical features of aggressive evolution. Patient sex did not influence the analyzed parameters, except for tumor location, where right colon tumors are slightly more common in females.
引用
收藏
页数:15
相关论文
共 54 条
  • [1] Data Version: Globocan 2022 (Version 1.1). 8 February 2024
  • [2] Xi Y., Xu P., Global colorectal cancer burden in 2020 and projections to 2040, Transl. Oncol, 14, (2021)
  • [3] Arnold M., Sierra M.S., Laversanne M., Soerjomataram I., Jemal A., Bray F., Global patterns and trends in colorectal cancer incidence and mortality, Gut, 66, pp. 683-691, (2017)
  • [4] Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin, 68, pp. 394-424, (2018)
  • [5] Ferlay J., Colombet M., Soerjomataram I., Mathers C., Parkin D.M., Pineros M., Znaor A., Bray F., Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int. J. Cancer, 144, pp. 1941-1953, (2019)
  • [6] Wong M.C., Huang J., Lok V., Wang J., Fung F., Ding H., Zheng Z.-J., Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location, Clin. Gastroenterol. Hepatol, 19, pp. 955-966.e61, (2020)
  • [7] Rawla P., Sunkara T., Barsouk A., Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors, Gastroenterol. Rev./Przegląd Gastroenterol, 14, pp. 89-103, (2019)
  • [8] Zhang J., Dhakal I.B., Zhao Z., Li L., Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: Role of nutrition transition, Eur. J. Cancer Prev, 21, pp. 480-489, (2012)
  • [9] Torre L.A., Siegel R.L., Ward E.M., Jemal A., Global Cancer Incidence and Mortality Rates and Trends—An Update, Cancer Epidemiol. Biomark. Prev, 25, pp. 16-27, (2016)
  • [10] Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J. Clin, 71, pp. 209-249, (2021)